- Home
- PFSI vs BME Comparison
PFSI vs BME Comparison
Compare PFSI & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PFSI | BME |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 547.5M |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PFSI | BME |
|---|---|---|
| Price | $87.18 | $39.40 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $139.13 | N/A |
| AVG Volume (30 Days) | ★ 728.9K | 35.8K |
| Earning Date | 04-21-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | ★ 59.25 | N/A |
| EPS | ★ 9.30 | N/A |
| Revenue | ★ $984,629,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.35 | N/A |
| P/E Ratio | $9.39 | ★ N/A |
| Revenue Growth | ★ 3.05 | N/A |
| 52 Week Low | $83.66 | $34.18 |
| 52 Week High | $160.36 | $42.74 |
Technical Indicators
Market Signals| Indicator | PFSI | BME |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 22.41 |
| Support Level | N/A | $35.48 |
| Resistance Level | $104.38 | $42.55 |
| Average True Range (ATR) | 2.80 | 0.60 |
| MACD | 1.21 | -0.26 |
| Stochastic Oscillator | 35.69 | 1.45 |
Price Performance
Historical ComparisonAbout PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.